Thompson KM - Search Results

1

Modeling Poliovirus Transmission and Responses in New York State.

Thompson KM, Kalkowska DA, Routh JA, Brenner IR, Rosenberg ES, Zucker JR, Langdon-Embry M, Sugerman DE, Burns CC, Badizadegan K. Thompson KM, et al. J Infect Dis. 2024 Apr 12;229(4):1097-1106. doi: 10.1093/infdis/jiad355. J Infect Dis. 2024. PMID: 37596838

2

Correction to statements about lead in infant formula.

Badizadegan K, Thompson KM. Badizadegan K, et al. Among authors: thompson km. N Engl J Med. 1992 Oct 15;327(16):1178. doi: 10.1056/NEJM199210153271619. N Engl J Med. 1992. PMID: 1528226 Free article. No abstract available.

3

Lead in infant formula.

Badizadegan K, Thompson KM. Badizadegan K, et al. Among authors: thompson km. N Engl J Med. 1992 May 14;326(20):1361-2. doi: 10.1056/NEJM199205143262012. N Engl J Med. 1992. PMID: 1565154 No abstract available.

4

Value of information in nonfocal colonic biopsies.

Badizadegan K, Thompson KM. Badizadegan K, et al. Among authors: thompson km. J Pediatr Gastroenterol Nutr. 2011 Dec;53(6):679-83. doi: 10.1097/MPG.0b013e31822862d9. J Pediatr Gastroenterol Nutr. 2011. PMID: 21681109

5

The probability of undetected wild poliovirus circulation after apparent global interruption of transmission.

Kalkowska DA, Duintjer Tebbens RJ, Thompson KM. Kalkowska DA, et al. Among authors: thompson km. Am J Epidemiol. 2012 May 1;175(9):936-49. doi: 10.1093/aje/kwr399. Epub 2012 Mar 29. Am J Epidemiol. 2012. PMID: 22459121

6

Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs).

Duintjer Tebbens RJ, Pallansch MA, Kim JH, Burns CC, Kew OM, Oberste MS, Diop OM, Wassilak SG, Cochi SL, Thompson KM. Duintjer Tebbens RJ, et al. Among authors: thompson km. Risk Anal. 2013 Apr;33(4):680-702. doi: 10.1111/risa.12022. Epub 2013 Mar 7. Risk Anal. 2013. PMID: 23470192 Free PMC article.

7

Characterizing poliovirus transmission and evolution: insights from modeling experiences with wild and vaccine-related polioviruses.

Duintjer Tebbens RJ, Pallansch MA, Kalkowska DA, Wassilak SG, Cochi SL, Thompson KM. Duintjer Tebbens RJ, et al. Among authors: thompson km. Risk Anal. 2013 Apr;33(4):703-49. doi: 10.1111/risa.12044. Epub 2013 Mar 22. Risk Anal. 2013. PMID: 23521018

8

The potential impact of expanding target age groups for polio immunization campaigns.

Duintjer Tebbens RJ, Kalkowska DA, Wassilak SG, Pallansch MA, Cochi SL, Thompson KM. Duintjer Tebbens RJ, et al. Among authors: thompson km. BMC Infect Dis. 2014 Jan 29;14:45. doi: 10.1186/1471-2334-14-45. BMC Infect Dis. 2014. PMID: 24472313 Free PMC article.

9

Characterization of the Risks of Adverse Outcomes Following Rubella Infection in Pregnancy.

Thompson KM, Simons EA, Badizadegan K, Reef SE, Cooper LZ. Thompson KM, et al. Risk Anal. 2016 Jul;36(7):1315-31. doi: 10.1111/risa.12264. Epub 2014 Aug 5. Risk Anal. 2016. PMID: 25100307 Review.

10

Modeling strategies to increase population immunity and prevent poliovirus transmission in 2 high-risk areas in northern India.

Kalkowska DA, Duintjer Tebbens RJ, Thompson KM. Kalkowska DA, et al. Among authors: thompson km. J Infect Dis. 2014 Nov 1;210 Suppl 1:S398-411. doi: 10.1093/infdis/jit844. J Infect Dis. 2014. PMID: 25316861

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

453 results

Search Page